Lupin receives USFDA nod for Rifampin Capsules

Pharma major Lupin Limited Friday announced that its US-based subsidiary Lupin Pharmaceuticals, Inc has got approval from the US health regulator to sell a generic version of Sanofi Aventis’ Rifadin capsules, used to treat tuberculosis, in the American market.

New TB drugs being tested in India

Research institutes in the country are undertaking trials to test new drugs to treat tuberculosis including the drug-resistant variety, Health Minister Ghulam Nabi Azad said Friday.

FDA approves new tuberculosis drug

The drug named Sirturo - known chemically as bedaquilineas – is an alternative treatment for adults suffering from TB.